Emerald Mutual Fund Advisers Trust Replimune Group, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

$1.77 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$6.87 - $9.31 $1.48 Million - $2 Million	-214,997 Reduced 61.89%	132,413 $1.08 Million
Q4 2023 Feb 05, 2024	SELL	$6.75 - $16.18 $3.56 Million - $8.52 Million	-526,800 Reduced 60.26%	347,410 $2.93 Million
Q3 2023 Oct 26, 2023	SELL	$15.96 - $22.18 $426,802 - $593,137	-26,742 Reduced 2.97%	874,210 $15 Million
Q2 2023 Aug 10, 2023	BUY	$15.65 - $24.1 $1.53 Million - $2.35 Million	97,504 Added 12.14%	900,952 $20.9 Million
Q1 2023 May 04, 2023	SELL	$17.48 - $29.09 $2.84 Million - $4.73 Million	-162,490 Reduced 16.82%	803,448 $14.2 Million
Q3 2022 Oct 25, 2022	SELL	$15.6 - $21.15 $317,179 - $430,021	-20,332 Reduced 2.06%	965,938 $16.7 Million
Q1 2022 Apr 29, 2022	SELL	$15.24 - $29.75 $1.36 Million - $2.65 Million	-89,194 Reduced 8.29%	986,270 $16.7 Million
Q4 2021 Feb 02, 2022	BUY	$25.43 - $34.25 $1.49 Million - $2 Million	58,527 Added 5.76%	1,075,464 $29.1 Million
Q3 2021 Oct 28, 2021	BUY	$28.98 - $39.54 $7.64 Million - $10.4 Million	263,509 Added 34.97%	1,016,937 $30.1 Million
Q2 2021 Jul 29, 2021	SELL	$28.5 - $39.37 $6.11 Million - $8.44 Million	-214,435 Reduced 22.16%	753,428 $28.9 Million
Q1 2021 Apr 29, 2021	BUY	$30.22 - $45.57 $3.36 Million - $5.07 Million	111,260 Added 12.99%	967,863 $29.5 Million
Q4 2020 Jan 29, 2021	BUY	$23.5 - $52.65 $766,429 - $1.72 Million	32,614 Added 3.96%	856,603 $32.7 Million
Q3 2020 Oct 28, 2020	BUY	$18.85 - $27.0 $430,288 - $616,329	22,827 Added 2.85%	823,989 $19 Million
Q2 2020 Jul 28, 2020	BUY	$9.76 - $25.95 $218,516 - $580,994	22,389 Added 2.87%	801,162 $19.9 Million
Q1 2020 Apr 30, 2020	SELL	$8.9 - $19.08 $68,725 - $147,335	-7,722 Reduced 0.98%	778,773 $7.76 Million
Q4 2019 Jan 29, 2020	BUY	$11.61 - $17.21 $616,386 - $913,696	53,091 Added 7.24%	786,495 $11.3 Million
Q3 2019 Oct 31, 2019	BUY	$10.01 - $16.87 $216,556 - $364,965	21,634 Added 3.04%	733,404 $10.2 Million
Q2 2019 Jul 31, 2019	BUY	$12.51 - $17.28 $45,661 - $63,072	3,650 Added 0.52%	711,770 $10.4 Million
Q1 2019 May 01, 2019	BUY	$10.26 - $16.24 $837,646 - $1.33 Million	81,642 Added 13.03%	708,120 $10.8 Million
Q4 2018 Jan 31, 2019	BUY	$9.97 - $15.57 $1.03 Million - $1.61 Million	103,162 Added 19.71%	626,478 $6.27 Million
Q3 2018 Oct 31, 2018	BUY	$14.99 - $22.14 $7.84 Million - $11.6 Million	523,316 New	523,316 $8.43 Million

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

Baker Bros. Advisors LP New York, NY

11M
Shares

$155 Million
1.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

9.88M
Shares

$139 Million
0.01% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.87M
Shares

$68.4 Million
9.16% of portfolio
Redmile Group, LLC San Francisco, CA

4.78M
Shares

$67.2 Million
3.43% of portfolio
Black Rock Inc. New York, NY

4.71M
Shares

$66.2 Million
0.0% of portfolio

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $693M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account